Works matching IS 13524585 AND DT 2022 AND VI 28 AND IP 13
Results: 22
Inhibitory synaptic loss drives network changes in multiple sclerosis: An ex vivo to in silico translational study.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2010, doi. 10.1177/13524585221125381
- By:
- Publication type:
- Article
Cladribine-induced liver injury: Implications for practice.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2146, doi. 10.1177/13524585221125370
- By:
- Publication type:
- Article
Acute idiosyncratic liver injury after Cladribine treatment for multiple sclerosis: first case report and review on associated hepatic disorders.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2142, doi. 10.1177/13524585221125360
- By:
- Publication type:
- Article
Rethinking the MS brain: Synaptic loss and computational modelling of brain networks.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 1999, doi. 10.1177/13524585221124307
- By:
- Publication type:
- Article
Mechanisms of central brain atrophy in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2038, doi. 10.1177/13524585221111684
- By:
- Publication type:
- Article
Permanent tissue damage in multiple sclerosis lesions is associated with reduced pre-lesion myelin and axon volume fractions.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2027, doi. 10.1177/13524585221110585
- By:
- Publication type:
- Article
Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levels.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2081, doi. 10.1177/13524585221109761
- By:
- Publication type:
- Article
A disproportionality analysis for the association of central nervous system demyelinating diseases with COVID-19 vaccination using the World Health Organization pharmacovigilance database.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2112, doi. 10.1177/13524585221109397
- By:
- Publication type:
- Article
No increase of serum neurofilament light in relapsing-remitting multiple sclerosis patients switching from standard to extended-interval dosing of natalizumab.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2070, doi. 10.1177/13524585221108080
- By:
- Publication type:
- Article
Time-varying connectivity of the precuneus and its association with cognition and depressive symptoms in neuromyelitis optica: A pilot MRI study.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2057, doi. 10.1177/13524585221107125
- By:
- Publication type:
- Article
The impact of bariatric surgery on disease activity and progression of multiple sclerosis: A nationwide matched cohort study.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2099, doi. 10.1177/13524585221107095
- By:
- Publication type:
- Article
Mitochondrial measures in neuronally enriched extracellular vesicles predict brain and retinal atrophy in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2020, doi. 10.1177/13524585221106290
- By:
- Publication type:
- Article
Two years' effect of dimethyl fumarate on focal and diffuse gray matter pathology in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2090, doi. 10.1177/13524585221104014
- By:
- Publication type:
- Article
A randomized trial predicting response to cognitive rehabilitation in multiple sclerosis: Is there a window of opportunity?
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2124, doi. 10.1177/13524585221103134
- By:
- Publication type:
- Article
Paramagnetic rim lesions are associated with pathogenic CSF profiles and worse clinical status in multiple sclerosis: A retrospective cross-sectional study.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2046, doi. 10.1177/13524585221102921
- By:
- Publication type:
- Article
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2106, doi. 10.1177/13524585221102918
- By:
- Publication type:
- Article
Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2151, doi. 10.1177/13524585221099413
- By:
- Publication type:
- Article
Anti-CGRP therapies for migraine in multiple sclerosis patients.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2149, doi. 10.1177/13524585221096353
- By:
- Publication type:
- Article
Response to— Tracking the role of sphingolipids in MS: The dynamic nature of ceramide synthases.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2148, doi. 10.1177/13524585221084094
- By:
- Publication type:
- Article
Tracking the role of sphingolipids in MS: The dynamic nature of ceramide synthases.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2147, doi. 10.1177/13524585221084092
- By:
- Publication type:
- Article
Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 years.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2137, doi. 10.1177/13524585221079598
- By:
- Publication type:
- Article
Extended dosing of monoclonal antibodies in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2001, doi. 10.1177/13524585211065711
- By:
- Publication type:
- Article